Abstract:Brain ventricular and subcortical structures are heritable both in size and shape. Genetic influences on brain region size have been studied using conventional volumetric measures, but little is known about the genetic basis of ventricular and subcortical shapes. Here we developed pipelines to extract seven complementary shape measures for lateral ventricles, subcortical structures, and hippocampal subfields. Based on over 45,000 subjects in the UK Biobank and ABCD studies, 60 genetic loci were identified to be associated with brain shape features ( P < 1.09 × 10-10), 19 of which were not detectable by volumetric measures of these brain structures. Ventricular and subcortical shape features were genetically related to cognitive functions, mental health traits, and multiple brain disorders, such as the attention-deficit/hyperactivity disorder. Vertex-based shape analysis was performed to precisely localize the brain regions with these shared genetic influences. Mendelian randomization suggests brain shape causally contributes to neurological and neuropsychiatric disorders, including Alzheimer’s disease and schizophrenia. Our results uncover the genetic architecture of brain shape for ventricular and subcortical structures and prioritize the genetic factors underlying disease-related shape variations. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This research was partially supported by U.S. NIH grants MH086633 (HT.Z.), MH116527 (TF.L.), and U01HG011720 (Y.L.). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The individual-level data used in the present study have been openly available from the UK Biobank (<https://www.ukbiobank.ac.uk/>) and ABCD (<https://abcdstudy.org/>) studies. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes The individual-level data used in the present study can be obtained from the UK Biobank (<https://www.ukbiobank.ac.uk/>) and ABCD (<https://abcdstudy.org/>) studies. Our GWAS summary statistics will be shared on Zenodo and at the BIG-KP <https://bigkp.org/>. Our GWAS results will also be available via the interactive web browser at <http://165.227.78.169:443/>. <https://bigkp.org/>

Identifying Genetic Risk Variants Associated With Brain Volumetric Phenotypes Via K-Sample Ball Divergence Method

Partitioning Heritability Analyses Unveil the Genetic Architecture of Human Brain Multidimensional Functional Connectivity Patterns.

Genome-wide Association Analysis of 19,629 Individuals Identifies Variants Influencing Regional Brain Volumes and Refines Their Genetic Co-Architecture with Cognitive and Mental Health Traits

Whole Genome Association Study of Brain-Wide Imaging Phenotypes: A Study of the Ping Cohort.

Heritability of Regional Brain Volumes in Large-Scale Neuroimaging and Genetic Studies.

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Genome-Wide Association Analysis With Gray Matter Volume As A Quantitative Phenotype In First-Episode Treatment-Naive Patients With Schizophrenia

Beyond Volume: Unraveling the Genetics of Human Brain Geometry

A Bayesian Group Sparse Canonical Correlation Analysis Method for Brain Imaging Genomics

Robust and Discriminative Brain Genome Association Study

Guided Exploration of Genomic Risk for Gray Matter Abnormalities in Schizophrenia Using Parallel Independent Component Analysis with Reference

Genetic associations between bipolar disorder and brain structural phenotypes

Increasing Power for Voxel-Wise Genome-Wide Association Studies: the Random Field Theory, Least Square Kernel Machines and Fast Permutation Procedures.

Efficient multi-phenotype genome-wide analysis identifies genetic associations for unsupervised deep-learning-derived high-dimensional brain imaging phenotypes

Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries

Genome-wide association studies of brain imaging phenotypes in UK Biobank

Super-variants Identification for Brain Connectivity.

Inferring the Genetic Relationship Between Brain Imaging-Derived Phenotypes and Risk of Complex Diseases by Mendelian Randomization and Genome-Wide Colocalization.

Identification of Disease-Sensitive Brain Imaging Phenotypes and Genetic Factors Using GWAS Summary Statistics

Genetic influences on the shape of brain ventricular and subcortical structures

Multifaceted genomic risk for brain function in schizophrenia.